UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.20549

FORM 10-Q

(Mark One)

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the ~~three~~nine months period ended ~~March 31,~~September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to to

Commission File Number: 001-36210

LiqTech International, Inc.

(Exact name of registrant as specified in its charter)

Nevada		20-1431677
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

Industriparken 22C, DK 2750 Ballerup, Denmark
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: +45 3131 5941

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which

registered

Common Stock, $0.001 par value

LIQT

The Nasdaq Stock Market LLC

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐.

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check one):

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): Yes ☐ No ☒

As of ~~May 12,~~November 10, 2022, there were ~~21,352,688~~43,896,871 shares of common stock, $0.001 par value per share, outstanding.

Certain statements made in this Quarterly Report on Form 10-Q are “forward-looking statements” regarding the plans and objectives of management for future operations and market trends and expectations. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions involving the continued expansion of our business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control. This is especially underlined by the impacts from the COVID-19 pandemic, related supply chain disruptions, inflationary pressure, macro-economic uncertainty, and the European energy crisis on the Company, including the related effects to our business operations, results of operations, cash flows, and financial position. Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this Quarterly Report on Form 10-Q will prove to be accurate. ~~In light of~~Considering the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved.

Forward-looking statements include, but are not limited to, statements concerning:

Any forward-looking statement made by us herein speaks only as of the date on which such statement is made, and the Company undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events. New factors emerge from time to time, and it is not possible for management to predict all such factors, nor can we assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

The accompanying notes are an integral part of these unaudited financial statements.

	As of			As of			As of			As of
	March 31,			December 31,			September 30,			December 31,
	2022			2021			2022			2021
	(Unaudited)						(Unaudited)
Liabilities and Stockholders’ Equity

Current Liabilities:
Accounts payable	$	2,023,972		$	1,646,662		$	1,617,452		$	1,646,662
Accrued expenses		5,084,650			4,685,665			3,447,107			4,685,665
Current portion of finance lease obligations		367,171			373,824			321,788			373,824
Current portion of operating lease liabilities		871,682			846,544			511,240			846,544
Current portion of convertible note payable		10,080,000			8,400,000
Current portion of Convertible Note payable								-			8,400,000
Contract liabilities		692,640			914,828			635,167			914,828

Total Current Liabilities		19,120,115			16,867,523			6,532,754			16,867,523


Deferred tax liability		205,318			224,779			154,478			224,779
Other liabilities, net of current portion		61,547			346,939			-			346,939
Finance lease obligations, net of current portion		2,355,721			2,499,591			1,911,361			2,499,591
Operating lease liabilities, net of current portion		5,872,927			6,154,064			2,608,566			6,154,064
Convertible note payable, less current portion		3,964,273			6,186,936
Senior Promissory Notes, net								5,395,240			-
Convertible Note payable, less current portion								-			6,186,936

Total Long-term Liabilities		12,459,786			15,412,309			10,069,645			15,412,309

Total Liabilities		31,579,901			32,279,832			16,602,399			32,279,832


Stockholders' Equity:
Preferred stock; par value $0.001, 2,500,000 shares authorized, 0 shares issued and outstanding at March 31, 2022 and December 31, 2021		0			0
Common stock; par value $0.001, 100,000,000 shares authorized, 21,352,688 and 21,285,706 shares issued and outstanding at March 31, 2021 and December 31, 2021, respectively		21,352			21,285
Preferred stock; par value $0.001, 2,500,000 shares authorized, 0 shares issued and outstanding at September 30, 2022 and December 31, 2021								-			-
Common stock; par value $0.001, 100,000,000 shares authorized, 43,896,871 and 21,285,706 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively								43,896			21,285
Additional paid-in capital		71,089,613			70,910,902			96,785,016			70,910,902
Accumulated deficit		(56,928,352	)		(53,181,928	)		(65,188,075	)		(53,181,928	)
Accumulated other comprehensive loss		(5,331,290	)		(4,975,399	)		(7,591,903	)		(4,975,399	)

Total Stockholders' Equity		8,851,323			12,774,860			24,048,934			12,774,860

Total Liabilities and Stockholders' Equity	$	40,431,224		$	45,054,692		$	40,651,333		$	45,054,692

The accompanying notes are an integral part of these unaudited financial statements.

	For the Three Months Ended						For the Three Months Ended						For the Nine Months Ended
	March 31,						September 30,						September 30,
	2022			2021			2022			2021			2022			2021

Revenue	$	3,637,236		$	3,997,877		$	3,305,534		$	4,142,954		$	11,961,062		$	12,157,394
Cost of goods sold		3,391,695			3,883,262
Cost of Goods Sold								3,198,255			3,946,732			11,460,102			11,525,847

Gross Profit		245,541			114,615			107,279			196,222			500,960			631,547

Operating Expenses:
Selling expenses		1,059,948			1,009,498			676,420			1,205,849			2,932,881			3,417,933
General and administrative expenses		1,916,517			1,474,670			1,429,315			1,102,772			4,611,375			3,824,574
Research and development expenses		602,737			437,607			283,524			497,823			1,377,097			1,370,059
Restructuring costs								(1,964	)		-			1,786,863			-

Total Operating Expense		3,579,202			2,921,775			2,387,295			2,806,444			10,708,216			8,612,566

Loss from Operations		(3,333,661	)		(2,807,160	)		(2,280,016	)		(2,610,222	)		(10,207,756	)		(7,981,019	)

Other Income (Expense)
Interest and other income		99			0			1,870			-			344,593			-
Interest expense		(206,461	)		(40,419	)		(28,514	)		(235,318	)		(394,532	)		(491,335	)
Amortization discount on convertible note		(297,338	)		-
Amortization discount on Notes								(84,098	)		(292,129	)		(2,304,054	)		(543,933	)
Gain (Loss) on currency transactions		75,993			371,684			628,137			218,030			361,928			506,018
Gain on lease termination								(3,317	)		-			150,258			-
Gain on sale of fixed assets								(19	)		(8	)		642			1,126

Total Other Income (Expense)		(427,707	)		331,265			514,059			(309,425	)		(1,841,165	)		(528,124	)

Loss Before Income Taxes		(3,761,368	)		(2,475,895	)		(1,765,957	)		(2,919,647	)		(12,048,421	)		(8,509,143	)

Income Tax Benefit		(14,994	)		(16,466	)		(13,293	)		(15,691	)		(42,274	)		(47,650	)

Net Loss	$	(3,746,424	)	$	(2,459,429	)	$	(1,752,664	)	$	(2,903,956	)	$	(12,006,147	)	$	(8,461,493	)


Basic and Diluted Loss Per Share	$	(0.18	)	$	(0.11	)	$	(0.04	)	$	(0.13	)	$	(0.37	)	$	(0.39	)

Basic and Diluted Weighted Average Common Shares Outstanding		21,350,455			21,677,186			43,891,799			21,769,461			32,529,152			21,661,945

The accompanying notes are an integral part of these unaudited financial statements.

For the period ended ~~March 31,~~September 30, 2022 and ~~March 31,~~September 30, 2021

																													Accumulated Other
																							*Additional*						*Compre-*
					Additional						Accumulated Other						*Common Stock*						*Paid-in*			*Accumulated*			*hensive*
	Common Stock				Paid-in			Accumulated			Comprehensive						*Shares*			*Amount*			*Capital*			*Deficit*			*Income/(Loss)*			*TOTAL*
	Shares		Amount		Capital			Deficit			Income/(Loss)			TOTAL
BALANCE, December 31, 2021		21,285,706		21,285		70,910,092			(53,181,928	)		(4,975,399	)		12,774,860			21,285,706			21,285			70,910,092			(53,181,928	)		(4,975,399	)		12,774,860

Common stock issued in settlement of RSUs		66,982		67		(67	)								-			66,982			67			(67	)								-

Stock-based compensation						178,778									178,778									178,778									178,778

Currency translation, net												(355,891	)		(355,891	)														(355,891	)		(355,891	)

Net Loss				0		0			(3,746,424	)		0			(3,746,424	)											(3,746,424	)					(3,746,424	)

BALANCE, March 31, 2022		21,352,688		21,352		71,089,613			(56,928,352	)		(5,331,290	)		8,851,323			21,352,688			21,352			71,089,613			(56,928,352	)		(5,331,290	)		8,851,323

Common shares issued for cash at $0.50 per share, net of offering cost of $1,996,469, in May 2022																		22,535,850			22,536			24,430,992									24,453,528

Warrants issued in connection with Senior Promissory Notes																								664,704									664,704

Stock-based compensation																								221,472									221,472

Currency translation, net																														(614,575	)		(614,575	)

Net Loss																											(6,507,059	)					(6,507,059	)

BALANCE, June 30, 2022																		43,888,538			43,888			96,406,781			(63,435,411	)		(5,945,865	)		27,069,393

Common stock issued in settlement of RSUs																		8,333			8			(8	)								-

Adjustment to warrants issued in connection with Senior Promissory Notes																								(3,868	)								(3,868	)

Stock-based compensation																								382,111									382,111

Currency translation, net																														(1,646,038	)		(1,646,038	)

Net Loss																											(1,752,664	)					(1,752,664	)

BALANCE, September 30, 2022																		43,896,871			43,896			96,785,016			(65,188,075	)		(7,591,903	)		24,048,934

BALANCE, December 31, 2020		21,655,461		21,655		69,897,698			(42,054,968	)		(3,046,070	)		24,818,315			21,655,461			21,655			69,897,698			(42,054,968	)		(3,046,070	)		24,818,315

Common stock issued in settlement of RSUs		41,912		42		(42	)		0			0			0			41,912			42			(42	)								-

Stock-based compensation				0		102,388			0			0			102,388									102,388									102,388

Currency translation, net				0		0			0			(1,311,521	)		(1,311,521	)														(1,311,521	)		(1,311,521	)

Net Income									(2,459,429	)					(2,459,429	)											(2,459,429	)					(2,459,429	)

BALANCE, March 31, 2021		21,697,373		21,697		70,000,044			(44,514,397	)		(4,357,591	)		21,149,753			21,697,373			21,697			70,000,044			(44,514,397	)		(4,357,591	)		21,149,753

Common stock issued as commitment fee for Convertible Note																		80,000			80			531,649									531,729

Stock-based compensation																								125,076									125,076

Currency translation, net																														368,104			368,104

Net Loss																											(3,098,108	)					(3,098,108	)

BALANCE, June 30, 2021																		21,777,373			21,777			70,656,769			(47,612,505	)		(3,989,487	)		19,076,554

Common stock issued in settlement of RSUs																		8,333			8			(8	)								-

Exchange of common stock to prefunded warrants																		(500,000	)		(500	)		500									-

Stock-based compensation																								127,519									127,519

Currency translation, net																														(603,894	)		(603,894	)

Net Loss																											(2,903,956	)					(2,903,956	)

BALANCE, September 30, 2021																		21,285,706			21,285			70,784,780			(50,516,461	)		(4,593,381	)		15,696,223

	For the Three Months Ended
	March 31,						For the Nine Months Ended September 30,
	2022			2021			2022			2021
Cash Flows from Operating Activities:
Net Loss	$	(3,746,424	)	$	(2,459,429	)	$	(12,006,147	)	$	(8,461,493	)
Adjustments to reconcile net loss to net cash provided by (used in) operations:
Depreciation and amortization		746,357			631,217			2,260,060			1,968,011
Amortization of discount on convertible notes payable		297,338			0
Amortization of discount on Notes payable								2,304,054			543,933
Stock-based compensation		178,778			102,388			782,361			354,983
Change in deferred tax asset / liability		(14,944	)		(16,466)			(42,274	)		(47,650	)
Changes in assets and liabilities:
Gain on lease termination								(150,258	)		-
Gain on sale of fixed assets								(642	)		(1,126	)
Changes in operating assets and liabilities:
Accounts receivable		(237,953	)		657,926			(1,262,577	)		741,514
Inventory		(505,962	)		(138,918	)		5,728			94,319
Contract assets		(585,678	)		772,940			(485,469	)		628,368
Prepaid expenses and other current assets		(1,399,481	)		(261,232	)		(1,497,612	)		299,949
Accounts payable		414,995			(372,530	)		212,304			(188,035	)
Accrued expenses		209,038			(492,028	)		(1,028,428	)		599,086
Operating lease liabilities		(185,804	)		(205,056	)		(409,008	)		(755,503	)
Contract liabilities		(205,206	)		141,066			(165,028	)		(184,447	)
Income taxes benefits		0			336,232

Total Adjustments		(1,288,522	)		1,155,539			523,211			4,053,402

Net Cash used in Operating Activities		(5,034,944	)		(1,303,890	)		(11,482,936	)		(4,408,091	)

Cash Flows from Investing Activities:
Purchase of property and equipment		(183,031	)		(414,875	)		(792,523	)		(932,293	)
Proceeds from sale of fixed assets								642			1,126
Net cash paid for earn-out agreement								-			(321,574	)

Net Cash used in Investing Activities		(183,031	)		(414,875	)		(791,881	)		(1,252,741	)

Cash Flows from Financing Activities:
Payments on finance lease obligation		(91,807	)		(101,192	)		(259,197	)		(287,526	)
Interest payments on convertible note		(840,000	)		0
Proceeds from issuance of common stock and prefunded warrants								24,418,612			-
Proceeds from issuance of Senior Promissory Notes								6,000,000			-
Payments on Convertible Note								(16,800,000	)		14,283,333

Net Cash provided by Financing Activities		(931,807	)		(101,192	)		13,359,415			13,995,807

Gain (Loss) on Currency Translation		(112,537	)		(787,185	)		(968,601	)		(907,085	)

Net change in Cash and Restricted Cash		(6,262,319	)		(2,607,142	)		115,997			7,427,890

Cash and Restricted Cash at Beginning of Period		17,489,380			13,264,499			17,489,380			13,264,449

Cash and Restricted Cash at End of Period	$	11,227,061		$	10,675,307		$	17,605,377		$	20,692,339

The accompanying notes are an integral part of these unaudited financial statements.

The consolidated financial statements include the accounts of LiqTech International, Inc., the “Company” and its subsidiaries. The terms "Company", “us", "we" and "our" as used in this report refer to the Company and its subsidiaries, which are set forth below in Item 2, ~~the management's discussion~~Management's Discussion and ~~analysis section.~~Analysis of Financial Condition and Results of Operation. The Company engages in the development, design, production, marketing and sale of automated filtering systems, ceramic silicon carbide liquid applications and diesel particulate air filters in ~~North America,~~the Americas, Asia-Pacific, Europe, ~~Asia, Australia,~~ and ~~South America.~~the Middle East & Africa.

Consolidation -- The consolidated financial statements include the accounts of the Company, ~~and~~ its ~~wholly owned~~wholly-owned subsidiaries and its majority owned subsidiary. All material intercompany transactions and accounts have been eliminated in the consolidation.

~~Reclassification~~ – Certain amounts presented in previously issued financial statements have been reclassified to be consistent with the current period presentation. In the statement of operations and comprehensive loss, the Company has reclassified the prior year comparative amounts of general and administrative expenses and other expenses to be consistent with the current classification.

Functional Currency / Foreign currency translation -- The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The functional currency of LiqTech Holding, LiqTech Water, LiqTech Plastics, LiqTech Ceramics, LiqTech Water Projects and LiqTech Emission Control is the Danish Krone (“DKK”); the functional currency of LiqTech China is the Renminbi (“RMB”); the functional currency of LiqTech Germany is the Euro; and the functional currency of LiqTech Singapore is the Singapore Dollar. The Company’s reporting currency is the U.S. Dollar for the purpose of these consolidated financial statements. The balance sheet accounts of the foreign subsidiaries are translated into U.S. Dollars at the period-end exchange rates, and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021. Translation gains and losses are deferred and accumulated as a component of other comprehensive income (loss) in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.

Cash and Restricted Cash -- The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. As of ~~March 31,~~September 30, 2022 and December 31, 2021, the Company held ~~$1,899,255~~$1,314,637 and $2,125,695, respectively, of restricted cash. The restricted cash is held as security by a local financial institution for ensuring a leasing facility and for payment guarantees issued for the benefit of customers in connection with prepayments of sales orders and for warranties after the delivery of products.

Accounts held in each U.S. institution are insured by the Federal Deposit Insurance Company (“FDIC”) up to $250,000. At ~~March 31,~~September 30, 2022 and December 31, 2021 the Company had ~~$6,572,282~~respectively $14,198,027 and $11,346,826 in excess of the FDIC insured ~~limit, respectively.~~limit.

Accounts Receivable -- Accounts receivable consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts that reflects the Company’s best estimate of probable losses inherent in the ~~accounts~~Accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, age, financial information that is publicly accessible and other currently available evidence.

The roll-forward of the allowance for doubtful accounts for the ~~period~~periods ended ~~March 31,~~September 30, 2022 and December 31, 2021 ~~are~~is as follows:

Inventory –-- Inventory directly purchased is carried at the lower of cost or net realizable value, as determined on the first-in, first-out method.

For inventory produced, standard costs that approximate actual costs, applying the FIFO method, are used to value inventory. Standard costs are reviewed at least annually by management or more often in the event that circumstances indicate a change in cost has occurred.

Work in process and finished goods include material, labor, and production overhead costs. The Company adjusts the value of its inventory to the extent management determines that the cost cannot be recovered due to obsolescence or other factors.

Inventory valuation adjustments for excess and obsolete inventory are calculated based on current inventory levels, movement, expected useful lives, and estimated future demand of the products and spare parts.

Contracts Assets / Liabilities –-- Contract assets are the Company’s rights to consideration in exchange for goods or services and is recognized when a performance obligation has been satisfied but has not yet been billed. When the Company issues invoices to the customer and the billing is higher than the capitalized Contract assets, the net amount is transferred to Contract liabilities. Contract assets/liabilities are transferred to revenue and cost of goods sold when the right to consideration is unconditional and billed per the terms of the contractual agreement.

Contract assets also include unbilled receivables, which usually comprise the last invoice remaining after the delivery of the water treatment unit, ~~where~~from which revenue is recognized at the transfer of control based upon signed acceptance ~~of the water treatment unit~~ by the customer. Most ~~commonly~~often this invoice is sent to the customer at commissioning of the product or no later than 12 months after the delivery. Also included in Contract assets are short-term receivables such as VAT and other receivables.

Leases -- The Company has elected to not recognize lease assets and liabilities with an initial term of 12 months or less and to not separate lease and non-lease components. The Company’s accounting for finance leases (formerly called capital lease obligations) remains substantially unchanged. Operating lease right-of-use (“ROU”) assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, an incremental borrowing rate based on the information available at the commencement date is used in determining the present value. The Company will use the implicit rate when readily determinable. The operating lease ROU asset also included prepaid lease payments, ~~and~~ reduced by accrued lease payments. The Company’s lease terms may include options to extend or terminate the lease, for which the Company will reflect the change when it is reasonably certain that those options will be exercised. Operating lease ~~cost~~costs for lease payments will be recognized on a straight-line basis over the lease term.

Property and Equipment -- Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from three to ten years.

Goodwill and Intangible Assets -- The purchase price of an acquired company is allocated between intangible assets and the net tangible assets of the acquired business, with the residual purchase price recorded as goodwill. The determination of the value of the intangible assets acquired involves certain judgments and estimates. These judgments can include, but are not limited to, the cash flows that an asset is expected to generate in the future and the appropriate weighted average cost of capital.

Acquired intangible assets with determinable useful lives are amortized on a straight-line or accelerated basis over the estimated periods benefited, ranging from one to ten years. Customer relationships and other non-contractual intangible assets with determinable lives are amortized over periods of five years.

The Company evaluates the recoverability of long-lived assets by comparing the carrying amount of an asset to the estimated future net undiscounted cash flows generated by the asset. If such assets are considered to be impaired, the impairment recognized is measured as the amount by which the carrying value of the assets exceeds the fair value of the assets. The evaluation of recoverability involves estimates of future operating cash flows based upon certain forecasted assumptions, including, but not limited to, revenue growth rates, gross profit margins, and operating expenses over the expected remaining useful life of the related asset. A shortfall in these estimated operating cash flows could result in an impairment charge in the future.

Goodwill is not amortized but is evaluated annually for impairment at the reporting unit level or when indicators of a potential impairment are present. The Company estimates the fair value of the reporting unit using the discounted cash flow and market approaches. Forecasts of future cash flows are based on the Company’s best estimate of future net sales and operating expenses, using primarily expected category expansion, pricing, market segment fundamentals, and general economic conditions.

Revenue Recognition -- On January 1, 2018, the Company adopted Accounting Standards Codification Topic 606, “Revenue from Contracts with Customers,” which includes clarifying ASUs issued in 2015, 2016 and 2017 (“new revenue standard”). The new revenue standard was applied to all open revenue contracts using the modified retrospective method as of January 1, 2018.

The Company sells products throughout the world, and sales by geographical region are as follows for the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021:

The Company’s sales by product ~~line~~and service are as follows for the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021:

For ~~liquid filters~~Water (systems and ~~systems, diesel~~aftermarket), Ceramics (diesel particulate filters and ~~plastic components,~~membranes), and Plastics (components), revenue is recognized when performance obligations ~~under~~specified within the terms of a contract with the customer are satisfied, which occurs when control of the product transfers to the customer or when services are rendered by the Company. The majority of the Company's sales contracts contain performance obligations satisfied at a point in time when title along with risks and rewards of ownership have transferred to the customer. This generally occurs when the product is shipped or accepted by the customer. Revenue for service contracts is recognized as the services are provided. Revenue is measured as the amount of consideration expected to be received in exchange for transferring the goods or providing services. The satisfaction of performance obligations under the terms of a revenue contract generally gives rise to the right to receive payment from the customer. The Company's standard payment terms vary by the type and location of the customer and the products or services offered. Generally, the time between when revenue is recognized and when payment is due is not significant. Pre-payments received prior to satisfaction of performance obligations are recorded as a Contract liability. Considering the relatively short time between revenue recognition and receipt of payment, financing components do not exist between the Company and its customers.

For contracts with customers that include multiple performance obligations, judgment is required to determine whether performance obligations specified in these contracts are distinct and should be accounted for as separate revenue transactions for recognition purposes. For such arrangements, revenue is allocated to each performance obligation based on its relative standalone selling price. Standalone selling prices are generally determined based on the prices charged to customers or using expected cost-plus margin.

System sales are recognized when the Company transfers control to the customer based upon sales and delivery conditions specified in the sales contract. This typically occurs upon shipment of the system from the production facility but can also occur upon other agreed delivery terms. In connection with the completion of the system, it is normal procedure to issue a FAT (Factory Acceptance Test) asserting that the customer has accepted the performance of the system as it is being shipped from our production facility in Hobro. As part of the performance obligation, the customer is normally offered commissioning services (final assembly and configuration at a place designated by the customer), and this commissioning is therefore considered a second performance obligation and is valued at cost, with the addition of a standard gross margin. This second performance obligation is recognized as revenue at the time of ~~provision of~~ the commissioning services being rendered together with the cost incurred. Part of the invoicing to the customer is also attributed to the commissioning, and at transfer of the control of the system (i.e., the first performance obligation), this portion is recognized as Contract ~~assets.~~liabilities.

Aftermarket sales represent parts, extended warranties and maintenance services. For the sale of aftermarket parts, the Company transfers control and recognizes revenue when parts are shipped to the customer. When customers are given the right to return eligible parts and accessories, the Company estimates the expected returns based on an analysis of historical experience. The Company adjusts estimated revenues at the earlier of when the most likely amount of consideration expected to be received changes or when the consideration becomes fixed. The Company recognizes revenue for extended warranty and maintenance agreements based on the standalone selling price over the life of the contract.

The Company has received long-term contracts for grants from government entities for the development and use of silicon carbide membranes in various water filtration and treatment applications and historically in the installation of various water filtration systems. We measure the transfer of control of the performance obligation on long-term contracts utilizing the cost-to-cost measure of progress, with cost of revenue including direct costs such as labor and materials. Under the cost-to-cost approach, the use of estimated costs to complete each performance obligation is a significant variable in the process of determining recognized revenue and a significant factor in the accounting for such performance obligations. The timing of when we bill our customers is generally dependent upon advance billings terms, milestone billings based on completion of certain phases of the work, or when services are provided or products are shipped. Projects with performance obligations recognized over time that have costs and estimated earnings recognized to date in excess of cumulative billings are reported on our balance sheet as Contract assets. Projects with performance obligations recognized over time that have cumulative billings in excess of costs and estimated earnings recognized to date are reported on our balance sheet as Contract liabilities.

Contract assets represent the Company’s rights to consideration in exchange for goods or services and is recognized when a performance obligation has been satisfied but has not yet been billed. Contract liabilities are payments received from customers prior to satisfaction of performance obligations, and these balances are typically related to prepayments for third-party expenses that are incurred shortly after billing. Contract assets/liabilities are transferred to revenue and cost of goods sold when the right to consideration is unconditional and billed per the terms of the contractual agreement. Contract liabilities also include deferred revenue related to the second performance obligation stated under Revenue Recognition, for which the obligation is attributed to the commissioning of the water treatment system.

The roll-forward of Contract assets / liabilities for the periods ended ~~March 31,~~September 30, 2022, and December 31, 2021 isare as follows:

Advertising Cost -- Costs incurred in connection with advertising of the Company’s products are expensed as incurred. Advertising costs are included in sales expenses, and total advertising costs for the three-month periods ended ~~March 31,~~September 30, 2022 and 2021 were ~~$55,524~~$39,094 and ~~$82,392,~~$41,141, respectively. Total advertising costs amounted to $142,522 and $166,376 for the nine months ended September 30, 2022 and 2021, respectively.

Research and Development Cost -- The Company expenses research and development costs as incurred. Included in operating expense for the three-month periods ended ~~March 31,~~September 30, 2022 and 2021 were research and development costs of ~~$602,737~~$283,524 and ~~$437,607,~~$497,823, respectively. For the nine-month periods ended September 30, 2022 and 2021, research and development costs were $1,377,097 and $1,370,059, respectively.

Income Taxes -- The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes. This statement requires an asset and liability approach with respect to accounting for income taxes.

Income/(Loss) Per Share -- The Company calculates earnings (loss) per share in accordance with FASB ASC 260, Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of shares of Common Stock outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential shares of Common Stock included in the diluted earnings per share calculation include in-the-money stock options, ~~RSU’s~~RSUs and warrants that have been granted but have not yet been exercised.

Stock Awards -- During the years presented in the accompanying consolidated financial statements, the Company has granted stock awards. The Company accounts for ~~options~~stock awards in accordance with the provisions of FASB ASC Topic 718, Compensation – Stock Compensation.

Fair Value of Financial Instruments -- The Company accounts for fair value measurements for financial assets and liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or non-recurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, other receivables, prepaid expenses, accounts payable, accrued expenses, Senior Promissory Notes and ~~convertible notes~~Convertible Notes payable approximate their recorded values due to their short-term maturities.

Accounting Estimates -- The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets including accounts receivable; allowance for doubtful accounts; contract assets; reserve for excess and obsolete inventory; depreciation and impairment of property, plant and equipment; goodwill; liabilities including contract liabilities and contingencies; the disclosures of contingent assets and liabilities at the date of the financial statements; and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

Recent Accounting Pronouncements –-- In November 2021, the FASB issued ASU 2021-10, Disclosures by Business Entities about Government ~~Assistance:~~Assistance. The FASB is issuing this Update to increase the transparency of government assistance including the disclosure of (1) the types of assistance, (2) an entity’s accounting for the assistance, and (3) the effect of the assistance on an entity’s financial statements. The ASU will be effective for annual reporting periods after ~~December 15, 2021.~~January 1, 2022. We are still assessing the impact of ASU 2021-10 on our consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06 ~~Debt—Debt with Conversion and Other Options (Subtopic~~ ~~470~~-20~~) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic~~ ~~815~~-40): Accounting for Convertible Instruments and Contracts in anAn Entity’s Own Equity. ~~This~~ ASU2020-06 simplifies the accounting for certain convertible instruments by removing the separation models for convertible debt with a cash conversion feature and for convertible instruments with a beneficial conversion feature. As a result, more convertible debt instruments will be reported as a single liability instrument with no separate accounting for embedded conversion features. Additionally, ASU 2020-06 amends the ~~guidance on~~diluted earnings per share calculation for convertible instruments ~~and~~by requiring the ~~derivatives scope exception for contracts in an entity’s own equity and improves and amends~~use of the ~~related EPS guidance for both Subtopics.~~if-converted method. The treasury stock method is no longer available. For SEC filers, excluding smaller reporting companies, ASU ~~will be~~2020-06 is effective for ~~annual reporting~~fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities, ASU 2020-06 is effective for fiscal years beginning after December 15, 2023, ~~and~~including interim periods within those ~~annual periods, and early~~fiscal years. Early adoption is permitted, ~~in annual reporting periods ending~~but no earlier than fiscal years beginning after December 15, ~~2020.~~2020, ~~We are still assessing the impact of~~including interim periods within those fiscal years. The Company early adopted ASU 2020-06 on ~~our condensed consolidated financial statements.~~January 1, 2022, using a modified retrospective approach.

In March 2020, the FASB issued ASU 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. This ASU provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The new guidance provides optional expedients and exceptions for applying GAAP to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. This ASU is intended to help stakeholders during the global market-wide reference rate transition period and will be in effect for a limited time through December 31, 2022. Adoption is permitted at any time. The Company is currently evaluating the impact on its financial statements.

Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going ~~concern. However,~~concern; however, the Company has ~~limited cash and~~ incurred significant recent ~~losses. These factors raise~~losses, which raises substantial doubt about the ability of the Company to continue as a going concern for a period of one year from the issuance of these financial statements. There is no assurance that the Company will be successful in ~~raising additional cash through~~executing the ~~issuance of debt or equity instruments or return to~~proposed cost reductions and revenue growth, thus achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.

During the second quarter, the Company completed a restructuring program to reduce costs, decrease operating losses and improve cash flow. Total restructuring and restructuring-related net charges pursuant to this program were $1,786,863, which were recorded separately in the income statement as “restructuring costs”, and allocated as follows:

CEO separation -- On May 10, 2022, the Board of Directors accepted the resignation of Sune Mathiesen as Chief Executive Officer and a director of the Company, effective May 12, 2022. As previously announced, Mr. Mathiesen had been on a medical leave of absence since March 17, 2022. In connection with Mr. Mathiesen’s resignation, Mr. Mathiesen and the Company entered into a Separation Agreement and Release (the “Separation Agreement”). Under the provisions of the Separation Agreement, Mr. Mathiesen received DKK1,605,000 (equivalent to $230,538), which is the equivalent of six months of salary, car allowance and pension contributions, in a lump-sum payment, less applicable deductions and withholdings.

Terminated employees – In the second quarter of 2022, the Company re-aligned its corporate management structure, which involved a reduction in headcount and labor costs of approximately 25%. The new organization reflects a focused effort to align key leaders with strategic imperatives, inspire greater accountability and performance management, eliminate silos and layers of middle management, and operate a leaner, more efficient business. Provisions for salary obligations to employees amounted to $159,841, reflecting the costs related to select employees released from duties with immediate effect. No provisions were made for the employees working during the notice period.

China close-down – In the second quarter of 2022, the Company reduced and suspended planned capital investments, including the Company’s program to build a manufacturing and service center in China. Pursuant to the suspended plans, the Company terminated and settled agreements with consultants, select project employees, and domestic property development providers, resulting in a net payment of termination and cancellation charges of $278,391.

Capex commitments -- As part of efforts to balance future investments with expected demands and cash flow, the Company commenced the renegotiation of all material Capex commitments during the quarter, with the ambition to reduce, cancel, or delay deliveries under the contracts, which initially amounted to approximately $9,000,000. Substantial progress was made during the second quarter, with expected closure of the renegotiation in the second half of 2022. As part of the renegotiation, a provision was made during the second quarter of $668,606 regarding expected cancellation charges and contractual termination costs. However, during this quarter the amount of paid cancellation charges has exceeded the provision by $28,607, which explains the total amount regarding capex commitments of $697,213.

Write-downs -- The re-routing of production equipment and machinery to Denmark (originally planned for China), resulted in a write-down of $243,075 on legacy installed equipment and machinery that was decommissioned as part of the arrival and implementation of new and more efficient equipment. Furthermore, review of obsolete inventory and existing product demand resulted in a write-down of $177,804.

The Company’s restructuring costs are as follows for the nine months ended September 30, 2022, of which $1,763,015 has been settled, resulting in $23,848 remaining unsettled as of September 30, 2022:

The following table displays a roll-forward of the restructuring accruals, presented within “accrued expenses”, for the nine months ended September 30, 2022 and 2021:

Inventory consisted of the following on ~~March 31,~~September 30, 2022, and December 31, 2021:

Inventory valuation adjustments for excess and obsolete inventory are calculated based on current inventory levels, movements, expected useful lives, and estimated future demand for the products.

During the third quarter the Company made further provisions for excess and obsolete inventory in a period with changing market fundamentals.

The Company leases certain vehicles, real property, production equipment and office equipment under lease agreements. The Company evaluates each lease to determine its appropriate classification as an operating lease or finance lease for financial reporting purposes. The majority of our operating leases are non-cancelable operating leases for production and office space in Hobro, Aarhus and Copenhagen, ~~Denmark as well as~~Denmark. During the second quarter of 2022, the Company terminated the lease agreement for the office and production space in Taicang, China.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, cash paid for ~~amounts included for the measurement of~~ finance lease liabilities was ~~$91,807,~~$316,246, and the Company recorded finance lease expenses in other income (expenses) of ~~$71,952.~~$221,928.

During the ~~three~~nine months ended ~~March 31,~~September 30, 2022, cash paid for ~~amounts included for the measurement of~~ operating lease liabilities was ~~$285,599,~~$733,390, and the Company recorded operating lease expense of ~~$341,076.~~$812,032.

Supplemental balance sheet information related to leases as of ~~March 31,~~September 30, 2022, and December 31, 2021 was as follows:

Maturities of lease liabilities at ~~March 31,~~September 30, 2022 were as follows:

In connection with certain orders, ~~we provide~~ the ~~customer~~Company provides to customers a working guarantee, a prepayment guarantee or a security bond. For that purpose, ~~we have~~the Company has a guaranteed credit line of EUR ~~1,750,000 (approximately $1,850,000)~~1,350,000 (approx. $1,315,000) secured by a cash deposit. As of ~~March 31,~~September 30, 2022, our bank has issued working guaranties of ~~$484,063 for our~~$306,327 to customers against the credit ~~line..~~

On March 24, 2021, wethe Company entered into a Securities Purchase Agreement with an institutional investor pursuant to which the Company agreed to issue and sell a $15.0 million principal amount senior ~~convertible note~~Convertible Note (the “Note”) ~~due~~maturing on October 1, 2023 and 80,000 shares of our common stock, $0.001 par value (“Common Stock”) for an aggregate purchase price of $15.0 million upon the satisfaction of the closing conditions set forth in the Securities Purchase Agreement. The Closing occurred on April 8, 2021, and the Company issued to the Investor the securities in connection with the Closing.

The Note iswas a senior, unsecured obligation of the Company, payable at 112% of the principal amount at maturity ( October 1, 2023), or earlier upon redemption or repurchase as set forth in the Note. The Note iswas convertible into shares of Common Stock pursuant to the terms of the Note, in part or in whole, from time to time, at the election of the Investor. The initial conversion rate iswas 100.6749 shares of Common Stock per $1,000 of principal amount of the Note. The conversion rate iswas subject to anti-dilution adjustments, including for stock dividends, splits and combinations; issuances of options, warrants or similar rights; spin-offs and distributions of property; cash dividends or distributions; and tender or exchange offers, in each case as further described in and pursuant to the terms of the Note.

~~The Note has interest payable quarterly beginning~~ ~~June 1, 2021,~~ ~~at a rate of 5% per annum. The number of shares issuable if the Company elects to pay interest in shares of Common Stock shall be based on the Market Price.~~

~~The Company~~ ~~may~~ ~~provide written notice to the Holder electing to convert the entire Principal Amount of the Note if (~~1~~) the Daily VWAP per share of Common Stock exceeds~~ ~~one hundred~~ ~~and~~ ~~seventy-five~~ ~~percent (175%) of the Conversion Price on each of~~ ~~twelve~~ (12~~) consecutive VWAP Trading Days beginning after~~ ~~September 24, 2021;~~ ~~and (~~2~~) the Equity Conditions are satisfied on each of such~~ ~~twelve~~ (12~~) consecutive VWAP Trading Days.~~

Beginning on March 1, 2022, and on the first day of each calendar month thereafter, at the election of the Investor or Holder, if applicable, the Company ~~shall be~~was required to redeem $840,000 of the amounts due under the Note in cash or Common Stock at 90% of the lesser of (i) the volume-weighted average price (“VWAP”) of the Common Stock on the trading day immediately preceding the payment date and (ii) the average of the lowest three (3) VWAPs over the 10 trading days immediately preceding the payment date, which shall in no case be less than the floor price of $1.75 per share. OnBeginning on March 1, 2022, the Company paid the first monthly installment of $840,000 in ~~cash.~~cash, totaling $3,360,000.

As of June 22, 2022, the Note, including accrued interest and all relevant obligations, was repaid in full, amounting to $13,446,875, allocated between a principal repayment of $11,640,000 and contractual repayment premium of $1,806,875.

For the three months ended ~~March 31,~~September 30, 2022 and 2021, the Company recognized ~~interests~~interest expense of ~~$187,500~~$0 and ~~$0,~~$481,712, respectively, and ~~$297,338~~$0 and ~~$0,~~$292,129, respectively, related to the amortization of debt issuance costs.

On June 22, 2022, the Company issued and sold Senior Promissory Notes in an aggregate principal amount of $6.0 million (the "Notes") and issued warrants to purchase 4,250,000 shares of common stock of the Company to affiliates of Bleichroeder L.P., 21April Fund, L.P., and 21April Fund, Ltd. (together, the "Purchasers"), pursuant to a note and warrant purchase agreement entered into with the Purchasers.

The Notes have a term of 24 months and do not bear interest during this period. However, if the notes are not repaid on or before the second anniversary of issuance, the Notes will thereafter bear interest of 10% per annum, which will increase by 1% each month the Notes remain unpaid, up to a maximum of 16% per annum, payable monthly.

Additionally, as part of the transaction, the Company issued 230,000 warrants to the placement agent. All of the warrants issued in this transaction have an exercise price of $0.65 per share, a term of five years and are exercisable for cash at any time.

As a result, the Company recorded an initial debt discount of $664,704, based on the relative fair value of the warrants and notes issued. The Company determined the fair value of the warrants by using the Black-Scholes Option Pricing Model, with the following assumptions: expected term of 2.5 years, stock price of $0.43, exercise price of $0.65, volatility of 80.8%, risk-free rate of 3.13%, and no forfeiture rate. The debt discount will be accreted according to the effective interest method over the contractual term of the note. The warrants qualified for equity classification and were reported within Additional Paid-In Capital.

For the three months ended September 30, 2022, and 2021, the Company recognized interest expense of $84,098 and $0, respectively, related to the amortization of the debt discount.

For the nine months ended September 30, 2022, and 2021, the Company recognized interest expense of $90,989 and $0, respectively, related to the amortization of the debt discount.

~~Agreements~~ -- LiqTech is planning to establish a joint venture to supply and operate water treatment systems for oil and gas producers in the Middle East. The partner in the joint venture is a local company. LiqTech expects to deliver technological know-how along with the design of water treatment systems and components to support potential projects in the Middle East. The joint venture will be established in the form of a jointly-owned limited liability company, incorporated under the laws in the local country, and LiqTech is expected to hold 49% of the shares. All profits of the company are to be allocated proportionally to the ownership share, and ~~none~~ ~~of the parties is liable for the company’s liabilities towards~~ ~~third~~ ~~parties.~~

Contingencies -- From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business.

OnThe Company has during the ~~February 27, 2019,~~ third~~LiqTech was contacted by~~ quarter been in dialogue with a former ~~supplier alleging that the Company owed DKK 543,905 ($81,177) for services rendered~~client regarding marine waste-water treatment systems delivered in ~~2017.~~2019, ~~The claimant has previously filed a lawsuit to claim payment for the services, which was denied by the Company~~regarding potential warranty claims due to ~~severe errors~~corrosion on select parts and component, with a total estimated remediation cost of $ 1.5 million. The Company is disputing the claim in ~~the services rendered. The claim was settled out of court and the Company agreed to pay DKK 400,000 ($59,700) for~~ full ~~and final~~however a commercial settlement is currently being discussed with expected completion during the ~~period ending~~ ~~March 31, 2022.~~fourth quarter or early 2023.

~~The Company entered arbitration on~~ ~~March 31, 2022~~ regarding a commercial dispute related to the delivery of a water treatment system installed on a commercial power plant. The parties disagree on whether the supplied equipment performs according to the agreed performance criteria. The dispute also relates to equipment down time and the use of additives to operate the equipment. The claim against LiqTech amounts to DKK 1,671,768 ($249,510) with the addition of interest with LiqTech disputing the claim including having filed a counterclaim regarding unpaid invoices. The parties are currently discussing an out of court settlement.

Product Warranties --- The Company provides a standard warranty for its systems, generally for a period of one to three years after customer acceptance. The Company estimates the costs that may be incurred under its standard warranty programs and records a liability for such costs at the time product revenue is recognized.

In addition, the Company sells an extended warranty for certain systems, which generally provides a warranty for up to four years from the date of commissioning. The specific terms and conditions of the warranties vary depending upon the product sold and the country in which the installation occurred. Revenue received for the sale of extended warranty contracts is deferred and recognized in the same manner as the costs incurred to perform under the warranty contracts.

The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Factors that affect the warranty liability include the number of units sold, historical and anticipated rates of warranty claims and the cost per claim.

Changes in the Company's ~~current and long-term~~ warranty obligations included in accrued expenses on the balance sheet, as of ~~March 31,~~September 30, 2022 and December 31, 2021, were as follows:

Basic and diluted net income (loss) per common share is determined by dividing net income (loss) by the weighted average number of shares of Common Stock outstanding during the period. For the periods where there is a net loss, stock options, warrants and Restricted Stock Units (“RSUs”) have been excluded from the calculation of diluted net loss per common share because their effect would be anti-dilutive. Consequently, the weighted average number of shares of Common Stock used to calculate both basic and diluted net loss per common share ~~are~~is the same for the reported periods.

For the period ended ~~March 31,~~September 30, 2022, the Company had ~~561,862~~outstanding balances of 2,504,340 RSUs, ~~outstanding~~31,440,000 prefunded warrants and ~~1,015,000 prefunded~~4,480,000 warrants, all exercisable for shares of Common ~~Stock outstanding.~~Stock.

The following table shows the amounts used in computing earnings per share and the weighted average number of shares of potentially dilutive Common Stock for the three and ninemonths ended ~~March 31,~~September 30, 2022, and 2021:

For the three and ninemonths ended ~~March 31,~~September 30, 2022 and 2021, respectively, the Company had 0no options ~~outstanding to purchase common stock.~~

Common Stock –-- The Company has 100,000,000 authorized shares of common stock, $0.001 par value ("Common Stock"). As of ~~March 31,~~September 30, 2022 and 2021, there were ~~21,352,688~~43,896,871 and ~~21,697,373~~21,285,706 shares of Common Stock issued and outstanding, respectively.

Voting -- Holders of common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors.

Dividends -- Subject to the rights and preferences of the holders of any series of preferred stock, if any, which may at the time be outstanding, holders of Common Stock are entitled to receive ratably such dividends as our Board of Directors from time to time may declare out of funds legally available.

Liquidation Rights -- In the event of any liquidation, dissolution or winding-up of affairs, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Common Stock will be entitled to share ratably in the distribution of any of our remaining assets.

Other Matters -- Holders of common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to our common stock. All of the issued and outstanding shares of common stock on the date of this Annual Report are validly issued, fully paid and non-assessable.

Preferred Stock -- Our Board of Directors has the authority to issue preferred stock in one or more classes or series and to fix the designations, powers, preferences and rights, qualifications, limitations, or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of preferred stock may have the effect of delaying, deferring, or preventing a change in control without further action by the stockholders and may adversely affect the voting and other rights of the holders of Common Stock.

The Company has 2,500,000 authorized ~~Preferred~~shares of preferred stock, $0.001 par value. As of ~~March 31,~~September 30, 2022, there were 0no shares of preferred ~~shares~~stock issued and outstanding.

Since January 1, 2022, the Company has made the following issuances of Common Stock:

On January 3, 2022, the Company issued 18,641 shares of Common Stock to settle ~~RSUs. The~~ RSUs ~~were valued at $140,000~~ for services provided by the Board of Directors in 2021. ~~The Company recognized the stock-based compensation of the award over the requisite service period.~~

On January 3, 2022, the Company issued 48,341 shares of Common Stock to settle ~~RSUs. The~~ RSUs ~~were valued at $299,196~~ for services provided by management in 2021. ~~The~~

On May 17, 2022, the Company ~~is recognizing the stock-based compensation~~issued 15,635,850 shares of Common Stock as part of the ~~award over~~ $23,000,000 public offering of common stock and 30,425,000 prefunded warrants to fund working capital, general corporate purposes, and partial repayment of its Senior Convertible Note.

On May 19, 2022, the ~~requisite service period.~~Company exercised in full the option to issue 6,900,000 shares of Common Stock as part of the overallotment of $3,450,000, resulting in the closing of its previously announced public offering of $26,450,000 to fund working capital, general corporate purposes, and partial repayment of its Senior Convertible Note. Total transaction costs related to the combined public offering of $26,450,000 amounted to $1,996,472.

On August 25, 2022, the Company issued 8,333 shares of Common Stock to settle RSUs for services provided by the Board of Directors.

~~In connection with the securities purchase agreement entered in~~ ~~May 2020,~~ we issued a prefunded warrant (“the Warrant”) to purchase an aggregate of 515,000 shares of Common Stock at a purchase price of $5.00 per share. Subject to certain beneficial ownership limitations, the Warrant is immediately exercisable and ~~may~~ ~~be exercised for~~ no ~~additional consideration. The Warrant does~~ ~~not~~ ~~expire. A holder of the Warrant will~~ ~~not~~ ~~have the right to exercise any portion of the Warrant if the holder, together with Affiliates and Attribution Parties (as such terms are defined in the Warrant), would beneficially own in excess of~~ ~~9.99%~~ of the number of shares of Common Stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrant. Upon notice from the holder to the Company, however, the holder ~~may~~ ~~decrease or increase the beneficial ownership limitation (but~~ ~~not~~ ~~above~~ ~~9.99%~~ ~~of the number of shares of Common Stock outstanding).~~

On August 17, 2021, the Company entered an exchange agreement with an existing shareholder to exchange an aggregate of 500,000 shares of Common Stock for equivalent shares of prefunded warrants (the “Exchange Agreement”). The prefunded warrants will be exercisable at an exercise price of $0.001 per share, subject to adjustments as provided under the terms of the prefunded warrants. The prefunded warrants will be exercisable at any time on or after the closing date. The Exchange Agreement contained additional terms typical of exchange agreements including representations and warranties of the parties. In connection with and as of the date of the Exchange Agreement, the Company issued the prefunded warrants to the shareholder, and the prefunded warrants are exercisable on ~~or after~~ August 17, 2021, subject to the limitations on exercise and conditions set forth by the prefunded warrants. The prefunded warrants ~~are~~became subject to customary adjustments in the event of stock splits and dividends, fundamental transactions, and subsequent offerings of rights to purchase stock.

~~The following~~On May 17, 2022, the Company entered a warrant purchase agreement with existing shareholders to purchase 30,425,000 shares of common stock at an offering price of $0.499 per prefunded warrant, which represents the offering price of $0.50 per share of the Company’s common stock less the $0.001 per share exercise price for each pre-funded warrant, for total gross proceeds of approximately $15,182,075 as part of the Company’s public offering of common stock and pre-funded warrants totaling $23,000,000 before underwriting discounts, commissions and offering expenses payable by the Company.

On June 23, 2022, the Company completed a private placement of Senior Notes in an aggregate principal amount of $6,000,000 and warrants to purchase 4,250,000 shares of common stock of the Company to affiliates of Bleichroeder L.P., 21April Fund, L.P., and 21April Fund, Ltd. (together, the "Purchasers"), pursuant to a note and warrant purchase agreement. Additionally, as part of the transaction, the Company issued 230,000 warrants to the placement agent. All warrants issued in this transaction have an exercise price of $0.65 per share, a term of five years and are exercisable for cash at any time.

Below is a summary of the periodic changes in warrants outstanding for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 and 2021:

In 2013, the Company’s Board of Directors adopted a Share Incentive Plan (the “Incentive Plan”). Under the terms and conditions of the Incentive Plan, the Board of Directors is empowered to grant RSUs to officers and directors of the Company. At ~~March 31,~~September 30, 2022, ~~561,862~~2,504,340 RSUs were granted and outstanding under the Incentive Plan. Directors of the Company receive share compensation as follows: an initial grant of 25,000 RSUs of Common Stock that vest over a three-year period upon appointment to the Board, followed by an annual grant of $36,750 ($73,500 for the Chairman of the Board) in RSUs per annum after full vesting of the initial grant. Further, the Company has granted shares of Common Stock in the ~~period ending~~ ~~March 31, 2022,~~ third quarter to management as part of the Incentive Plan, totaling ~~454,249~~722,456 shares ~~that~~of which 97,456 shares vest in January 2023 (part of Interim CEO agreement amended on September 13, 2022) and the remaining shares vest over a three-year period.

The Company recognizes compensation costs for RSU grants to directors and management based on the stock price on the date of the grant.

The Company recognized stock-based compensation expense related to RSU grants of ~~$178,778~~$382,111 and ~~$102,388~~$127,519 for the three-month ~~period~~periods ended ~~March 31,~~September 30, 2022 and 2021, respectively. For the nine months periods ended September 30, 2022, and 2021, the stock-based compensation related to share grants was $782,360 and $354,983, respectively. On ~~March 31,~~September 30, 2022, the Company had ~~$1,949,981~~$827,939 of unrecognized compensation cost related to non-vested stock grants.

A summary of the status of the RSUs as of ~~March 31,~~September 30, 2022 and changes during the period are presented below:

NOTE 1011 -– SIGNIFICANT CUSTOMERS / CONCENTRATION / DISAGGREGATED REVENUE

The following table presents customers accounting for 10% or more of the Company’s revenue:

The following table presents customers accounting for 10% or more of the Company’s Accounts receivable:

As of ~~March 31,~~September 30, 2022, ~~and~~ ~~December 31, 2021,~~ approximately ~~100%~~62% of the Company’s assets were located in ~~Denmark.~~

Denmark, 36% were located in the U.S., and 2% were located in China. As of December 31, 2021, approximately 61% of the Company’s assets were located in Denmark, 26% were located in the U.S., and 13% were located in China.

The Company operates in three segments: Water, Ceramics and Plastics. Effective as of January 1, 2020, the group structure was changed, with shared group activities transferred to an individual reporting unit separated from the business units. Costs and assets for these activities were therefore separated during 2020.

In ~~April 2022,~~ None.the Company re-aligned its corporate management structure, which involved a reduction in headcount and labor costs of approximately 25%. The new organization reflects a focused effort to align key leaders with strategic imperatives, inspire greater accountability and performance management, eliminate silos and layers of middle management, and operate a leaner, more efficient business.

On ~~May 11, 2022,~~ the Company entered into a separation and release agreement with Sune Mathiesen, the Company’s Chief Executive Officer (“CEO”). Mr. Mathiesen had previously taken a medical leave of absence announced in ~~March 2022.~~ LiqTech has retained Heidrick & Struggles, a leading international executive search firm, to assist the Company in a search for a new, permanent CEO. The Company’s current Interim Chief Executive Officer, Alexander J. Buehler, has agreed to maintain the position of Interim CEO for the foreseeable future until a permanent candidate is identified and a proper transition is conducted.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read in conjunction with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this quarterly report. In addition, the following discussion should be read in conjunction with our annual report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 31, 2022 and the financial statements and notes thereto. We undertake no obligation to revise or publicly release the results of any revision to these forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

LiqTech International, Inc. is a clean technology company that provides state-of-the-art gas and liquid purification products by manufacturing ceramic silicon carbide filters and membranes. For more than two decades, we have developed and manufactured products of re-crystallized silicon carbide. We specialize in three business areas: ceramic membranes for liquid filtration systems, diesel particulate filters (DPFs) to control soot exhaust particles from diesel engines, and plastic components for usage in various industries. Using nanotechnology, we develop proprietary products using patented silicon carbide technology. Our products are based on unique silicon carbide membranes that facilitate new applications and improve existing technologies. We market our products from our office in Denmark and through local representatives and distributors. The products are shipped directly to customers from our production facilities in Denmark.

The terms “LiqTech”, “we”, “our”, “us”, the “Company” or any derivative thereof, as used herein, refer to LiqTech International, Inc., a Nevada corporation, together with its direct and indirect wholly owned subsidiaries, including LiqTech USA, Inc., a Delaware corporation (“LiqTech USA”), which owns all of the outstanding equity interest in LiqTech NA, Inc., a Delaware corporation (“LiqTech NA”) and in LiqTech Holding A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark (“LiqTech Holding”), together with its direct wholly owned subsidiaries LiqTech Ceramics A/S (“LiqTech Ceramics”), LiqTech Water A/S (“LiqTech Water”), LiqTech Plastics A/S (“LiqTech Plastics”), LiqTech Water Projects A/S ("LiqTech Water Projects”), LiqTech Emission Control A/S (“LiqTech Emission Control”), all Danish limited companies organized under the Danish Act on Limited Companies of the Kingdom of Denmark, and LiqTech Environment Technologies (China) Co., Ltd. (“LiqTech China”), a Chinese company organized under the Chinese Act on Limited Companies in the Peoples Republic of China. Collectively, LiqTech USA, LiqTech NA, LiqTech Holding, LiqTech Ceramics, LiqTech Water, LiqTech Plastics, LiqTech Water Projects, LiqTech Emission Control and LiqTech China are referred to herein as our “Subsidiaries”.

At present, we conduct our operations in the Kingdom of Denmark. Our Danish operations are located in the Copenhagen area, in Hobro, and in Aarhus.

Our strategy is to leverage our core competencies in material science, ~~fluid dynamics,~~advanced filtration, and systems integration, creating differentiated products with compelling value propositions to penetrate attractive end markets with regulatory and ESG tailwinds. Essential imperatives associated with our strategy include the following:

The financial information below is derived from our unaudited condensed consolidated financial statements included elsewhere in this report.

The following table sets forth our revenues, expenses and net loss for the three months ended ~~March 31,~~September 30, 2022 and 2021:

	Three Months Ended March 31,																		Three Months Ended September 30,
													Period to Period Change																		Period to Period Change
	2022			As a % of Sales			2021			As a % of Sales			Variance			Percent %			2022			As a % of Sales			2021			As a % of Sales			Variance			Percent %
Revenue		3,637,236			100.0	%		3,997,877			100.0	%		(360,641	)		(-9.0	)%		3,305,534			100.0	%		4,142,954			100.0	%		(837,420	)		(20.2	)%
Cost of goods sold		3,391,695			93.2			3,883,262			97.1			(491,567	)		(12.7	)
Cost of Goods Sold																				3,198,255			96.8			3,946,732			95.3			(748,477	)		(19.0	)
Gross Profit		245,541			6.8			114,615			2.9			130,926			114.2			107,279			3.2			196,222			4.7			(88,943	)		(45.3	)

Operating Expenses
Selling expenses		1,059,948			29.1			1,009,498			25.3			50,450			5.0			676,420			20.5			1,205,849			29.1			(529,429	)		(43.9	)
General and administrative expenses		1,916,517			52.7			1,474,670			36.9			441,847			30.0			1,429,315			43.2			1,102,772			26.6			326,543			29.6
Research and development expenses		602,737			16.6			437,607			10.9			165,130			37.7			283,524			8.6			497,823			12.0			(214,299	)		(43.0	)
Restructuring costs																				(1,964	)		(0.1	)		-			-			(1,964	)		-
Total Operating Expenses		3,579,202			98.4			2,921,775			73.1			657,427			22.5			2,387,295			72.2			2,806,444			67.7			(419,149	)		(14.9	)

Loss from Operation		(3,333,661	)		(91.7	)		(2,807,160	)		(70.2	)		(526,501	)		(18.8	)		(2,280,016	)		(69.0	)		(2,610,222	)		(63.0	)		330,206			(12.7	)

Other Income (Expense)
Interest and other income		99			-			-			-			99			100.0			1,870			0.1			-			-			1,870			-
Interest (expense)		(206,461	)		(5.7	)		(40,419	)		(1.0	)		(166,042	)		410.8			(28,514	)		(0.9	)		(235,318	)		(5.7	)		206,804			(87.9	)
Amortization discount, convertible note		(297,338	)		(8.2	)		-			-			(297,338	)		100.0
Amortization discount, Notes																				(84,098	)		(2.5	)		(292,129	)		(7.1	)		208,031			(71.2	)
Gain (loss) on currency transactions		75,993			2.1			371,864			9.3			(295,691	)		(79.6	)		628,137			19.0			218,030			5.3			410,107			188.1
Gain on lease termination																				(3,317	)		(0.1	)		-			-			(3,317	)		-
Gain (loss) on sale of fixed assets																				(19	)		-			(8	)		0.0			(11	)		137.5
Total Other Income (Expense)		(427,707	)		(11.8	)		331,365			8.3			(758,972	)		(229.1	)		514,059			15.6			(309,425	)		(7.5	)		823,484			(266.1	)

Loss Before Income Taxes		(3,761,368	)		(103.4	)		(2,475,895	)		(61.9	)		(1,285,473	)		(51.9	)		(1,765,957	)		(53.4	)		(2,919,647	)		(70.5	)		1,153,690			(39.5	)
Income Tax Benefit		(14,944	)		(0.4	)		(16,466	)		(0.4	)		1,522			0.1			(13,293	)		(0.4	)		(15,691	)		(0.4	)		2,398			(0.2	)

Net Loss		(3,746,424	)		(103.0	)		(2,459,429	)		(61.5	)		(1,286,995	)		(52.3	)		(1,752,664	)		(53.0	)		(2,903,956	)		(70.1	)		1,151,292			(39.6	)

Revenue for the three months ended ~~March 31,~~September 30, 2022, was ~~$3,637,236~~$3,305,534 compared to ~~$3,997,877~~$4,142,954 for the same period in 2021, representing a decrease of ~~$360,641,~~$837,420, or 9%20%. The decrease was ~~attributable~~particularly attributed to a ~~decline~~reduction in ~~sales~~deliveries of ~~liquid filters,~~ water treatment systems of $708,503 and ~~DPFs~~a decrease in Plastics revenue of ~~$685,213,~~$190,389 amid general market uncertainty exacerbated by the European energy crisis, partly offset by an increase in Ceramics revenue of $151,924 due to increased sales of ~~plastic components of $324,572. The decrease in liquid filters~~membranes and ~~water treatment systems largely reflect~~large-scale DPF deliveries for the downturn in the marine industry during the COVID-19 pandemic, whereas the decline in DPFs reflects general market conditions and delays in orders due to continued supply chain constraints. The increase in plastics components was a result of dedicated sales effort and increased market penetration.Asian market.

Gross profit for the three months ended ~~March 31,~~September 30, 2022, was ~~$245,541~~$107,279 compared to gross profit of ~~$114,615~~$196,222 for the same period in 2021, representing ~~an increase~~a decrease of ~~$130,926.~~$88,943. The ~~increase in gross profit compared to last year~~decrease was mainly caused by ~~an improvement in sales mix and elevated profitability from sales of plastics components as well as spare-parts and commission activities, partly offset by~~ the continued negative impact from rising input cost inflation associated with the production of our silicon carbide products, ~~more specifically increased~~including increases in electricity, ~~and~~ raw material prices, labor, ~~cost inflation, and general price increased on~~ freight and logistic services. The gross profit in the third quarter was further impacted by adjustments for excess and obsolete inventory in a period with changing market fundamentals, resulting in write-downs of select items and implementation of revised standard cost calculations. The negative impact was partly offset by deliveries of high-margin Ceramics membranes and increased aftermarket sales during the quarter. Included in the gross profit was depreciation of ~~$496,049~~$436,257 and ~~$471,885~~$473,327 for the three months ended ~~March 31,~~September 30, 2022 and 2021, respectively.

Total operating expenses for the three months ended ~~March 31,~~September 30, 2022 were ~~$3,579,202,~~$2,387,295, representing ~~an increase~~a decrease of ~~$657,427,~~$419,149, or ~~23%~~15%, compared to ~~$2,921,775~~$2,806,444 for the same period in ~~2021.~~2021, mainly reflecting the cost reduction, restructuring, and reorganization efforts implemented in 2022.

Selling expenses for the three months ended ~~March 31,~~September 30, 2022 were ~~$1,059,948~~$676,420 compared to ~~$1,009,498~~$1,205,849 for the same period in 2021, representing ~~an increase~~a decrease of ~~$50,450,~~$529,429, or ~~5%, due~~44%. This decline was the result of, organizational streamlining that included a reduction in headcounts of seven compared to same period in 2021, partly offset by increased ~~costs associated with direct sales, consulting services,~~marketing and ~~intensified marketing activities.~~ travel activities following the easing of COVID-19 restrictions.

General and administrative expenses for the three months ended ~~March 31,~~September 30, 2022, were ~~$1,916,517~~$1,429,315 compared to ~~$1,474,670~~$1,102,772 for the same period in 2021, representing an increase of ~~$441,847,~~$326,543, or 30%. The increase was mainly driven by project management and leasehold expenses in China, coupled with the implementation of a new ERP platform, general recruitment costs, and an increase in overall headcount from 12 as of March 31, 2021 to 14 as of March 31, 2022. Included in general and administrative expenses was increased non-cash compensation of ~~$178,778~~$254,592 related to onboarding of new CFO, CEO, and ~~$102,388 for the three months ended March 31, 2022~~interim CEO agreement, and ~~2021, respectively.~~increased employee expenses related to onboarding of key staff, partly offset by a decrease in legal expenses.

Research and development expenses for the three months ended ~~March 31,~~September 30, 2022, were ~~$602,737~~$283,524 compared to ~~$437,607~~$497,823 for the same period in 2021, representing ~~an increase~~a decrease of ~~$165,130,~~$214,299, or ~~38%~~43%. The ~~increase~~decrease represents a reduction in the number of external development projects along with efficiencies and saving achieved through the streamlining and centralization of the R&D function.

Restructuring costs for the three months ended September 30, 2022, were $(1,964) compared to $0 for the same period in 2021, representing additional restructuring costs for the completion of ~~several development projects during~~ the ~~quarter as well as an increase~~restructuring program announced in the ~~average number~~second quarter (see Note 3), offset by the continued appreciation of ~~employees engaged in research~~the USD against EUR and ~~development activities from 14 as of March 31, 2021, to 17 as of March 31, 2022.~~DKK.

Other Income ~~(Expenses)~~ for the three months ended ~~March 31,~~September 30, 2022, was ~~$(427,707)~~$514,059 compared to ~~$331,265~~Other Expenses of $309,425 for the comparable period in 2021, representing a ~~decrease~~positive variance of ~~$758,972. This~~$823,484. The change was mainly related to a decrease in interest expenses and amortization discount of $414,835, explained by the refinancing of the Convertible Note ~~issued in April 2021, with $297,338 for the amortization discount and $187,500 for interest expenses, along with a reduction~~ in the second quarter of 2022 with the new $6 million Senior Promissory Note and gain on currency transactions ~~due to a less favorable DKK/USD exchange rate during the period~~ of $410,107.

Net loss for the three months ended ~~March 31,~~September 30, 2022, was ~~$(3,746,424)~~$1,752,664 compared to ~~$(2,459,429)~~$2,903,956 for the comparable period in 2021, representing a decrease in net loss of $1,151,292, supported by the intensified cost reduction efforts, gain on currency transactions, and the benefits from the refinancing of the Convertible Note.

The following table sets forth our revenues, expenses and net loss for the nine months ended September 30, 2022 and 2021:

Revenue for the nine months ended September 30, 2022, was $11,961,062 compared to $12,157,394 for the same period in 2021, representing a decrease of $196,332, or 1.6%. The decrease was mainly driven by increased Plastics revenue of $153,517 and Ceramics revenue of $104,088, offset by the continued appreciation of the USD against the EUR due to revenue denominated in DKK or EUR, coupled with lower share of completed development projects of $245,098 and reduced Water revenue of $208,840.

Gross profit for the nine months ended September 30, 2022, was $500,960 compared to gross profit of $631,547 for the same period in 2021, representing a decrease of $130,587. The change reflects reduced profitability within the Plastics and Ceramics businesses due to unfavorable mix, further exacerbated by continued input cost inflation and the European energy crisis. Proactive measures such as price increases and power price surcharges have been launched by the company to defend profitability. Included in the gross profit was depreciation of $1,406,003 and $1,440,382, for the nine months ended September 30, 2022 and 2021, respectively.

Total operating expenses for the nine months ended September 30, 2022, were $10,708,216, representing an increase of $2,095,650, or 24%, compared to $8,612,566 for the same period in 2021, mainly driven by restructuring costs of $1,786,863 recognized in the second quarter of 2022.

Selling expenses for the nine months ended September 30, 2022, were $2,932,881 compared to $3,417,933 for the same period in 2021, representing a decrease of $485,052, or 14%. The decrease is explained by the cost reduction and reorganization efforts initiated in 2022, and more specifically headcounts reductions and organization streamlining, partly offset by increased costs associated with intensified direct sales efforts, consulting service engagements, direct marketing activities, and bad debt provisions.

General and administrative expenses for the nine months ended September 30, 2022, were $4,611,375 compared to $3,824,574 for the same period in 2021, representing an increase of $786,801, or 21%. The increase was mainly caused by increased headcount and costs associated with the China capacity expansion, recruitment of key employees, and general legal and audit costs. Also included in general and administrative expenses for the period was increased cost associated with the recent CEO transition that included increased non-cash compensation of $782,361 for the nine months ended September 30, 2022, compared to $354,983 in the same period in 2021.

Research and development expenses for the nine months ended September 30, 2022, were $1,377,097 compared to $1,370,059 for the same period in 2021, representing an increase of $7,038, or 0.5%.

Restructuring costs for the nine months ended September 30, 2022, were $1,786,863 compared to $0 for the same period in 2021. The restructuring program was executed in the second quarter (See Note 3).

Other Expense for the nine months ended September 30, 2022, was $1,841,165 compared to $528,124 for the comparable period in 2021, representing a negative variance of $1,313,040.

The variance was mainly related to the early repayment of the Convertible Note issued in April 2021, reflecting the full recognition of the repayment premium and amortization cost in the second quarter of 2022. Further, the period was impacted by a lower gain on currency transactions of $144,090, partly offset by the receipt of COVID-19 grants in the Danish entities and gain on lease terminations.

Net loss for the nine months ended September 30, 2022, was $12,006,147 compared to $8,461,493 for the comparable period in 2021, representing an ~~increase~~unfavorable variance in net loss of ~~$1,286,995.~~$3,544,653.

This change was primarily attributable to the ~~reduced revenue, increased operating expenses,~~restructuring charges, and ~~other expenses including interest and amortization discount pertaining~~refinancing cost related to the repayment of the Convertible ~~Note.~~Note in the second quarter.

Based on the ~~prolonged negative effects of~~continued, and more recently increased market volatility and geopolitical unrest pertaining to the ~~global pandemic~~Russia and ~~other current global geopolitical issues, we are~~Ukraine conflict, European energy crisis and highly inflationary environment, and macro-economic uncertainty, the Company is unable to predict the full impact ~~that these~~this will have on our long-term financial condition, results of operations, liquidity, and cash flows. ~~Our compliance~~The Company has planned and executed on decisive measures in 2022 to help safeguard the business and its financial position by reducing cost, headcount, and overall capex commitments, which together with the ~~measures implemented to avoid~~successful completion of the ~~spread~~$26.45 million public offering of ~~COVID-19 has clearly had a material adverse impact on our financial results since March 2020.~~ common stock and pre-funded warrants, substantially improve the near-term liquidity position of the Company.

Furthermore, in June the Company completed the refinancing of its $15 million Convertible Note due in 2023, partly funded by the issuance of the new $6 million Senior Promissory Notes due in June 2024 along with the proceeds from the public offering. The Senior Promissory Notes are interest-free, with full redemption after 24 months.

Based on current projections, which are subject to significant uncertainties, including the duration and severity of ~~these~~ global ~~macro-economic~~macroeconomic issues, ~~we believe our~~commodity volatility, and continued global supply chain disruptions, the Company believes the cash on hand, as well as ~~our~~ ongoing cash generated from operations, ~~might not~~will be sufficient to cover ~~our~~its capital requirements and committed investments for the next 12 ~~months based on the reported financials ended March 31, 2022 including committed investments to generate revenue growth. In addition, as a result of the~~months.

Continued market uncertainty and reduced order intake continued supply chain disruptions and decreased manufacturing levels, our gross profit will also likely be unfavorably impacted until such time that we are able to operate our manufacturing facilities at the higher capacity levels that were originally planned prior tocaused by weakening global macroeconomic conditions, recession, or a resurgence of the COVID-19 ~~pandemic. Notwithstanding~~pandemic, however, could unfavorably impact the ~~reduction in our manufacturing levels~~Company’s ability to generate positive cash flow and ~~continued supply chain disruptions, based on our current rate of production, we believe that we will be able to fulfill most, if not all, of our existing delivery obligations in 2022.~~thereby significantly reduce the profitability and liquidity position.

While ~~we anticipate~~the Company anticipates that its proactive measures will be sufficient to protect and fund the ~~foregoing measures are temporary, we~~business over the coming 12 months, the Company cannot predict the specific duration ~~for which these precautionary measures will stay in effect nor how our~~and severity of the unfavorable market dynamics that may adversely affect the business ~~may be adversely affected~~ as a result of these global economic issues and associated supply chain disruptions. In the future, wethe Company may experience reduced or changed demand for ~~our~~its products and services, especially if there is a global recession or structural ~~shifts~~shift in ~~the~~regulation or demand for ~~our~~its products across ~~our~~its core end markets. ~~We could also experience limitations to our ability to produce and ship products resulting from governmental actions and regulations along with further disruptions in the global supply chain.~~

~~We have~~The Company has historically satisfied ~~our~~its capital and liquidity requirements through offerings of equity instruments, internally generated cash from operations and our available lines of credit. ~~At the filing date,~~On September 30, 2022, the Company had an available line of credit amounting to DKK 20,000,000 (approximately $3,000,000), which was used for a leasing arrangement and guarantees issued to customers for prepayments and warranties after delivery. On March 31, 2022, we had cash of ~~$11,227,061~~$17,605,377 and net working capital of ~~$5,158,696,~~$23,306,125, and on December 31, 2021, wethe Company had cash of $17,489,380 and net working capital of ~~$11,199,259. On March 31, 2022, our net~~$11,199,258. The increase in working capital ~~had decreased by $6,040,563~~of $12,106,867 compared to December 31, 2021 is mainly as a result of ~~a reduction in cash~~the capital raise and ~~cash equivalents and an increase in the current portion~~repayment of the Convertible Note.

In connection with certain orders, we provide the customer a working guarantee, a prepayment guarantee or a security bond. For that purpose, we maintain a guaranteed credit line of ~~EUR1,750,000~~EUR 1,350,000 (approximately ~~$1,850,000)~~$1,315,000). The credit line is secured by a cash deposit.

On March 24, 2021, wethe Company entered into a Securities Purchase Agreement with an institutional investor pursuant to which the Company agreed to issue and sell a $15.0 million principal amount senior ~~convertible note~~Convertible Note (the “Note”) due on October 1, 2023, and 80,000 shares of ~~our~~ common stock, $0.001 par value (“Common ~~Stock~~Stock”), for an aggregate purchase price of $15.0 million upon the satisfaction of the closing conditions set forth in the Securities Purchase Agreement. The Closing occurred on April 8, 2021, and the Company issued to the Investor the securities in connection with the Closing.

The Note iswas a senior, unsecured obligation of the Company, payable at 112% of the principal amount at maturity (October 1, 2023), or earlier upon redemption or repurchase as set forth in the Note. The Note iswas convertible into shares of Common Stock pursuant to the terms of the Note, in part or in whole, from time to time, at the election of the Investor. The initial conversion rate iswas 100.6749 shares of Common Stock per $1,000 of principal amount of the Note. The conversion rate iswas subject to anti-dilution adjustments including ~~for:~~for stock dividends, splits and combinations; issuances of options, warrants or similar rights; spin-offs and distributions of property; cash dividends or distributions; and tender or exchange offers, in each case as further described in and pursuant to the terms of the Note.

The Note has interest payable quarterly beginning June 1, 2021, at a rate of 5% per annum. The number of shares issuable if the Company elects to pay interest in shares of Common Stock shall be based on the Market Price.

The Company may provide written notice to the Holder electing to convert the entire Principal Amount of the Note if (1) the Daily VWAP per share of Common Stock exceeds one hundred and seventy-five percent (175%) of the Conversion Price on each of twelve (12) consecutive VWAP Trading Days beginning after September 24, 2021; and (2) the Equity Conditions are satisfied on each of such twelve (12) consecutive VWAP Trading Days.

Beginning on March 1, 2022, and on the first day of each calendar month thereafter, at the election of the Investor or Holder, if applicable, the Company ~~shall be~~was required to redeem $840,000 of the amounts due under the Note in cash or Common Stock at 90% of the lesser of (i) the volume-weighted average price (“VWAP”) of the Common Stock on the trading day immediately preceding the payment date and (ii) the average of the lowest three (3) VWAPs over the 10 trading days immediately preceding the payment date, which shall in no case be less than the floor price of $1.75 per share. OnBeginning on March 1, 2022, the Company paid the first ~~installment~~monthly installments of $840,000 in ~~cash. On April 1, 2022 and May 1,~~cash, totaling $3,360,000.

As of June 22, 2022, the ~~Investor also elected~~Note, including accrued interests and all relevant obligations, was repaid in full, amounting to ~~receive~~$13,446,875, allocated to principal repayment of $11,640,000 and contractual repayment premium of $1,806,875.

On June 22, 2022, the ~~$840,000 payment~~Company issued and sold Senior Promissory Notes in ~~cash.~~an aggregate principal amount of $6.0 million (the "Notes") and issued warrants to purchase 4,250,000 shares of common stock of the Company to affiliates of Bleichroeder L.P., 21 April Fund, L.P., and 21 April Fund, Ltd. (together, the "Purchasers"), pursuant to a note and warrant purchase agreement entered into with the Purchasers.

The Notes have a term of 24 months and do not bear interest during this period. If the notes are not repaid on or before the second anniversary of issuance, however, the Notes will thereafter bear interest of 10% per annum, which will increase by 1% each month the Notes remain unpaid, up to a maximum of 16% per annum, payable monthly.

As a result, the Company recorded an initial debt discount of $664,704 based on the relative fair value of the warrants and notes issued. The Company determined the fair value of the warrants by using the Black-Scholes Option Pricing Model with the following assumptions: expected term of 2.5 years, stock price of $0.43, exercise price of $0.65, volatility of 80.8%, risk-free rate of 3.13%, and no forfeiture rate. The debt discount will be accreted according to the effective interest method over the contractual term of the note. The warrants qualified for equity classification and were reported within Additional Paid-In Capital.

~~Three~~Nine months ended ~~March 31,~~September 30, 2022 compared to ~~three~~nine months ended ~~March 31,~~September 30, 2021

Cash provided by (used in) operating activities for the period ending March 31, 2022 was resulted primarily from the net loss for the period and adjusted for certain non-cash items and changes in assets and liabilities. Cash used in operating activities for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 ~~was $(5,034,944), representing~~of $11,482,936 represents a decrease of ~~$3,731,054~~$7,074,845 compared to ~~cash used in operating activities of $(1,303,890)~~$4,408,091 for the ~~three~~nine months ended ~~March 31,~~September 30, 2021. ~~The cash used in operating activities for~~For the ~~three~~nine months ended ~~March 31,~~September 30, 2022, ~~consists~~the result is mainly ofexplained by the net loss for the period of ~~$(3,746,424)~~$12,006,147 adjusted for depreciation and other non-cash-related items of ~~$1,207,529.~~$5,153,301. Changes in assets and liabilities include increased Accounts receivable of ~~$237,953~~$1,262,577 and net Contract assets/liabilities of ~~$790,884,~~$650,497, with the latter ~~being explained~~caused by the delivery of a ~~work on~~ water treatment ~~systems for delivery~~system in ~~Q2 2022. Furthermore, Accrued~~the second quarter of 2022 with an extended service, commissioning, and payment schedule running until August 2025. The increase in prepaid expenses and ~~Accounts~~other current assets of $1,497,612 is related to prepayments on production equipment. Furthermore, accounts payable increased by ~~$209,038~~$212,304 and ~~$414,995 respectively.~~accrued expenses decreased by $1,028,428 due to repayment of COVID-19 loans provided by the Danish government.

Net cash used in investing activities was ~~$(183,031)~~$791,881 for the ~~three~~nine months ended ~~March 31,~~September 30, 2022, as compared to ~~$(414,875)~~$1,252,741 for the ~~three~~nine months ended ~~March 31,~~September 30, 2021, representing ~~an increase~~a decrease of $231,844. The investing activities include the purchase of production equipment in Ballerup to increase production capacity and the continued investment in the new ERP platform which is expected to be fully implemented in Q2 2022.$460,860.

Cash ~~used~~provided from financing activities was ~~$(931,807)~~$13,359,415 for the ~~three~~nine months ended ~~March 31,~~September 30, 2022 compared to ~~$(101,192)~~$13,995,807 for the ~~three~~nine months ended ~~March 31,~~September 30, 2021, representing ~~an increase~~a decrease of ~~$830,615. The increase was~~$636,392. For the nine-month period ended September 30, 2022, the change is mainly ~~driven~~explained by the equity capital raise in the second quarter, generating net proceeds of $24,418,612 from the issuance of common stock and prefunded warrants, combined with the $6,000,000 proceeds from the issuance of the new Senior Promissory Notes, and offset by the full repayment of ~~$840,000 regarding~~ the Convertible Note issued in April ~~2021. Further, cash from financing activities was negatively impacted by the payment~~2021 of ~~$91,806 related to the furnace lease agreement.~~

~~As of March 31, 2022, we had no off-balance sheet arrangements. We are not aware of any material transactions that are not disclosed in our consolidated financial statements.~~ $16,800,000.

The methods, estimates, and judgments that we use in applying our accounting policies have a significant impact on the results that we report in our consolidated financial statements. Some of our accounting policies require us to make difficult and subjective judgments, often as a result of the need to make estimates regarding matters that are inherently uncertain. Our most critical accounting estimates include:

For a description of accounting changes and recent accounting standards, including the expected dates of adoption and estimated effects, if any, on our consolidated financial statements, see “Note 1: Recently Enacted Accounting Standards” in the accompanying Financial Statements.

~~For a description of subsequent events, see “Note 12 – Subsequent Events”.~~None.

We are not required to provide quantitative and qualitative disclosures about market risk because we are a smaller reporting company.

Management, with the participation of our ~~Interim~~ Chief Executive Officer and our Chief Financial Officer, evaluated the design and effectiveness of our internal controls over financial reporting and disclosure controls and procedures (pursuant to Rule 13a-15(b) and (c) under the Exchange Act) as of the end of the period covered by this Quarterly Report. A weakness is a control deficiency, or combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a misstatement of the registrant's financial statements will not be prevented or detected on a timely basis.

There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance of achieving their control objectives.

Based upon that evaluation, our ~~Interim~~ Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures as of ~~March 31,~~September 30, 2022 were not effective as of the period covered by this Quarterly Report due to material weaknesses in internal controls over financial reporting. For more information on material weaknesses identified by management, please reference our Form 10-K filed on March 31, 2022 for the year ended December 31, 2021.

There was no change in our internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

In response to the identified material weaknesses, Company management, with oversight from the Company’s Audit Committee, has been and will continue to dedicate necessary resources to enhance the Company’s internal control over financial reporting and remediate the identified material weaknesses. As an example of such remediation, the Company has hired additional employees into the finance department, and we plan to continue to work on remediating the material weaknesses during 2022 by improving competencies and work processes. Further, an investment in a new ERP system has been made along with other supporting IT systems to ~~support~~reinforce the controls and processes of the Company. These investments are an important part of our remediation plan. Lastly, the Company has started the process of redesigning and ensuring documentation of all processes and procedures related to financial reporting to ensure the effective design and operation of process-level controls.

While management believes that the steps that have been taken and plan to take will improve the overall system of internal control over financial reporting and will remediate the identified material weaknesses, these material weaknesses cannot be considered fully remediated until the applicable relevant controls operate for a sufficient period of time.

An internal control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate.

While management believes that the steps that we have taken and plan to take will improve the overall system of internal control over financial reporting and will remediate identified material weaknesses, the material weaknesses cannot be considered remediated until the applicable relevant controls operate for a sufficient ~~period of time.~~period.

For a description of contingencies, see “Note 78 – Agreements ~~And~~and Commitments”.

~~Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.~~

On May 10, 2022, the Board of Directors accepted the resignation of Sune Mathiesen as Chief Executive Officer and a director of the Company effective May 12, 2022 (the “Separation Date”). As previously announced, Mr. Mathiesen has been on a leave of absence since March 17, 2022. In connection with Mr. Mathiesen’s resignation, on May 11, 2022, Mr. Mathiesen and the Company entered into a Separation Agreement and Release (the “Separation Agreement”). Under the Separation Agreement, Mr. Mathiesen will receive DKK1,605,000 (equivalent to US$227,080), which is the equivalent of six months of salary, car allowance and pension contributions, in a lump sum payment, less applicable deductions and withholdings within five days of the date of the Separation Agreement (the “Severance Amount”). In addition, Mr. Mathiesen agreed to cancel 144,000 unvested restricted stock units (“RSUs”), and return, for no value, 39,133 shares of common stock previously issued to him upon the vesting of RSUs, in exchange for 80,000 new RSUs which will vest on December 31, 2022, subject to Mr. Mathiesen’s compliance with the restrictive covenants set forth in the Separation Agreement.

The foregoing summary of the terms of the Separation Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of each, copies of which are attached as Exhibit 10.1 hereto.None.

In accordance with the requirements of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Page
PART I. FINANCIAL INFORMATION	5

Item 1. Financial Statements	5

Condensed Consolidated Balance Sheets as of ~~March 31,~~September 30, 2022 (unaudited) and December 31, 2021	5

Condensed Consolidated Statements of Operations and Comprehensive Loss for the Three and Nine Months Ended ~~March 31,~~September 30, 2022 and ~~March 31,~~September 30, 2021 (unaudited)	7

Condensed Consolidated Statement of Stockholder’s Equity for the period ended ~~March 31,~~September 30, 2022 and ~~March 31,~~September 30, 2021 (unaudited)	9

Condensed Consolidated Statements of Cash Flows for the ~~Three~~Nine Months Ended ~~March 31,~~September 30, 2022 and ~~March 31,~~September 30, 2021 (unaudited)	10

Notes to Condensed Consolidated Financial Statements (unaudited)	12

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operation	2628

Item 3. Quantitative and Qualitative Disclosures About Market Risk	3137

Item 4. Controls and Procedures	3137

PART II. OTHER INFORMATION	3238

Item 1. Legal Proceedings	3238

Item 1A. Risk Factors	3238

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	3238

Item 3. Defaults Upon Senior Securities	3238

Item 4. Mine Safety Disclosures	3238

Item 5. Other Information	3238

Item 6. Exhibits	3339

SIGNATURES	3440

	As of		As of		As of		As of
	March 31,		December 31,		September 30,		December 31,
	2022		2021		2022		2021
	(Unaudited)				(Unaudited)
Assets

Current Assets:
Cash and restricted cash	$	11,227,061	$	17,489,380	$	17,605,377	$	17,489,380
Accounts receivable, net of allowance for doubtful accounts of $312,677 and $409,076 at March 31, 2022 and December 31, 2021, respectively		2,152,606		1,957,579
Inventories, net of allowance for excess and obsolete inventory of $262,901 and $268,470 at March 31, 2022 and December 31, 2021, respectively		5,809,602		5,421,027
Accounts receivable, net of allowance for doubtful accounts of $161,311 and $409,076 at September 30, 2022 and December 31, 2021, respectively						2,843,864		1,957,579
Inventories, net of allowance for excess and obsolete inventory of $578,076 and $268,470 at September 30, 2022 and December 31, 2021, respectively						4,657,188		5,421,027
Contract assets		2,437,924		1,906,510		2,078,472		1,906,510
Prepaid expenses and other current assets		2,651,618		1,292,285		2,653,978		1,292,285

Total Current Assets		24,278,811		28,066,781		29,838,879		28,066,781

Long-Term Assets:
Property and equipment, net of accumulated depreciation of $7,829,488 and $7,554,803 at March 31, 2022 and December 31, 2021, respectively		8,383,826		8,858,993
Property and equipment, net of accumulated depreciation of $7,848,569 and $7,554,803 at September 30, 2022 and December 31, 2021, respectively						6,877,185		8,858,993
Operating lease right-of-use assets		6,613,073		6,925,807		3,119,806		6,925,807
Deposits and other assets		618,995		628,109		390,634		628,109
Intangible assets, net of accumulated amortization of $376,375 and $357,231 at March 31, 2022 and December 31, 2021, respectively		301,244		334,743
Intangible assets, net of accumulated amortization of $376,954 and $357,231 at September 30, 2022 and December 31, 2021, respectively						218,190		334,743
Goodwill		235,275		240,259		206,639		240,259

Total Long-Term Assets		16,152,413		16,987,911		10,812,454		16,987,911

Total Assets	$	40,431,224	$	45,054,692	$	40,651,333	$	45,054,692

	For the Three Months Ended March 31,				For the Nine Months Ended September 30,
	2022		2021		2022		2021
Supplemental Disclosures of Cash Flow Information:
Cash paid during the period for:
Interest	$	203,289	$	37,236	$	364,846	$	483,321
Income Taxes		0		0		-		-

Non-cash financing activities
Original issue discount on Convertible Note						-		1,800,000
Convertible Note debt conversion feature						-		3,048,396
Debt issuance costs on Convertible Note						-		716,667
Common Stock issued for conversion of Convertible Note						-		531,729
Debt discount on Senior Promissory Notes						695,749		-

	March 31, 2022			December 31, 2021			September 30, 2022			December 31, 2021
Allowance for doubtful accounts at the beginning of the period	$	409,076		$	498,044		$	409,076		$	498,044
Bad debt expense		(88,776	)		(28,499	)		91,519			(28,499	)
Receivables written off during the periods		0			(24,415	)		(298,850	)		(24,415	)
Effect of currency translation		(7,623	)		(36,054	)		(40,434	)		(36,054	)
Allowance for doubtful accounts at the end of the period	$	312,677		$	409,076		$	161,311		$	409,076

							For the Three months ended
	*% Distribution*						*March 31,*
	*2022*			*2021*			*2022*		*2021*
North America		4	%		4	%	$	139,307	$	165,588
Australia		1	%		1	%		35,399		32,141
Asia		22	%		28	%		799,965		1,157,155
Europe		73	%		67	%		2,662,564		2,642,993
		100	%		100	%	$	3,637,236	$	3,997,877

	For the Three Months				For the Nine Months
	Ended September 30,				Ended September 30,
	2022		2021		2022		2021
Americas	$	382,573	$	211,575	$	861,260	$	573,365
Asia-Pacific		895,696		636,622		2,944,449		3,225,691
Europe		1,903,930		3,294,757		6,651,065		8,358,338
Middle East & Africa		123,335		-		1,504,288		-
	$	3,305,534	$	4,142,954	$	11,961,062	$	12,157,394

							For the Three Months
	*% Distribution*						*Ended March 31,*
	*2022*			*2021*			*2022*		*2021*
Liquid filters and systems		16	%		30	%	$	592,990	$	1,157,336
Diesel particulate filters		52	%		48	%		1,880,118		1,931,064
Plastic components		31	%		20	%		1,138,597		814,025
Development projects		1	%		2	%		25,530		95,452
		100	%		100	%	$	3,637,236	$	3,997,877

●	Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;
●	Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
●	Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

	September 30, 2022
CEO separation	$	230,538
Terminated employees		159,841
China close-down		278,391
Capex commitments		697,213
Write-downs		420,880
	$	1,786,863

	2022			2021
Restructuring accruals, January 1	$	-		$	-
Restructuring costs, net		1,786,863			-
Cash payments		(1,342,135	)		-
Asset impairments		(420,880	)		-
Restructuring accruals, September 30	$	23,848		$	-

	Operating Lease			Finance lease			Operating Lease			Finance lease
2022 (remaining 9 months)	$	922,725		$	329,688
2022 (remaining 3 months)							$	176,803		$	97,263
2023		1,220,130			435,549			681,709			389,052
2024		1,072,809			436,488			552,318			389,876
2025		789,504			432,931			287,898			386,752
2026		814,186			396,284			278,383			354,565
Thereafter		3,782,380			955,968			2,157,468			846,130
Total payment under lease agreements		8,601,733			2,986,908			4,134,579			2,463,638
Less imputed interest		(1,857,124	)		(264,017	)		(1,014,773	)		(230,489	)
Total lease liability	$	6,744,609		$	2,722,891		$	3,119,806		$	2,233,149

	March 31, 2022			March 31, 2021
Convertible note	$	15,960,000			0
Less: unamortized debt issuance costs		(1,915,726	)		0
Convertible note payable	$	14,044,274		$	0

Current portion of convertible note payable		10,080,000			0
Convertible note payable, less current portion		3,964,273			0
Convertible note payable	$	14,044,274		$	0

	September 30, 2022			December 31, 2021
Senior Promissory Notes	$	6,000,000			-
Less: unamortized debt discount		(604,760	)		-
Senior Promissory Notes payable	$	5,395,240		$	-

Current portion of Senior Promissory Notes payable		-			-
Senior Promissory Notes payable, less current portion		5,395,240			-
Senior Promissory Notes payable	$	5,395,240		$	-

							For the Three Months						For the Nine Months
	For the Three Months Ended March 31,						Ended September 30,						Ended September 30,
	2022			2021			2022			2021			2022			2021
Net (Loss)	$	(3,746,424	)	$	(2,459,429	)		(1,752,664	)		(2,903,956	)		(12,006,147	)		(8,461,493	)
Weighted average number of common shares used in basic earnings per share		21,350,455			21,677,186			43,891,799			21,769,461			32,529,152			21,661,945
Effect of dilutive securities, stock options, RSUs, and warrants		0			0			-			-			-			-
Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share		21,350,455			21,677,186			43,891,799			21,769,461			32,529,152			21,661,945

	March 31, 2022								September 30, 2022
	Number of units			Weighted Average Grant-Date Fair value			Aggregated Intrinsic Value		Number of units			Weighted Average Grant-Date Fair value			Aggregated Intrinsic Value

Outstanding, December 31, 2021		149,636		$	6.59		$	0		149,636		$	6.59		$	-
Granted		479,208			3.34			-		2,574,871			0.77			-
Vested and settled with share issuance		(66,982	)		(6.56	)		-		(75,315	)		(6.59	)		-
Forfeited		-			-			-		(144,853	)		(6.22	)		-
Outstanding, March 31, 2022		561,862		$	3.82		$	0
Outstanding, September 30, 2022										2,504,340		$	0.63		$	-

	~~March 31,~~September 30, 2022			December 31, 2021
Customer BA		*	%		11	%
~~Customer C~~		*	%		17	%
~~Customer D~~		1214	%		*
Customer C		11	%		*
Customer E		*			16	%
Customer G		16*			11	%

	●	Develop and reinforce new products and applications to provide clean water and reduce ~~pollution~~pollution. We currently provide water filtration systems for scrubber technology providers, shipowners, and ship operators as well as tailored filtration systems for oil & gas operators and services companies. We are expanding our range of products to better leverage existing customer relationships and develop new relationships within the oil & gas, marine, and global chemical industries.

	●	Better penetrate existing end markets where our value proposition is ~~strong~~strong. We have successfully sold products and installed systems into several end markets--including automotive/transportation, clean water and pool filtration, marine, industrial wastewater, and oil & gas. We are focused on targeting and activating new customers in these end markets while working with distributors, agents, and partners to access other important geographic markets.

	Nine Months Ended September 30,
													Period to Period Change
	2022			As a % of Sales			2021			As a % of Sales			Variance			Percent %
Revenue		11,961,062			100.0	%		12,157,394			100.0	%		(196,332	)		(1.6	)%
Cost of Goods Sold		11,460,102			95.8			11,525,847			94.8			(65,745	)		(0.6	)
Gross Profit		500,960			4.2			631,547			5.2			(130,587	)		(20.7	)

Operating Expenses
Selling expenses		2,932,881			24.5			3,417,933			28.1			(485,052	)		(14.2	)
General and administrative expenses		4,611,375			38.6			3,824,574			31.5			786,801			20.6
Research and development expenses		1,377,097			11.5			1,370,059			11.3			7,038			0.5
Restructuring costs		1,786,863			14.9			-			-			1,786,863			-
Total Operating Expenses		10,708,216			89.5			8,612,566			70.8			2,095,650			24.3

Loss from Operation		(10,207,256	)		(85.3	)		(7,981,019	)		(65.6	)		(2,226,237	)		27.9

Other Income (Expense)
Interest and other income		344,593			2.9			-			-			344,593			-
Interest (expense)		(394,532	)		(3.3	)		(491,335	)		(4.0	)		96,804			(19.7	)
Amortization discount, Notes		(2,304,054	)		(19.3	)		(543,933	)		(4.5	)		(1,760,121	)		323.6
Gain (loss) on currency transactions		361,928			3.0			506,018			4.2			(144,090	)		(28.5	)
Gain on lease termination		150,258			1.3			-			-			150,258			-
Gain (loss) on sale of fixed assets		642			-			1,126			0.0			(484	)		(43.0	)
Total Other Income (Expense)		(1,841,165	)		(15.4	)		(528,124	)		(4.3	)		(1,313,040	)		248.6

Loss Before Income Taxes		(12,048,421	)		(100.7	)		(8,509,143	)		(70.0	)		(3,539,277	)		41.6
Income Tax Benefit		(42,274	)		(0.4	)		(47,650	)		0.4			5,376			(11.3	)

Net Loss		(12,006,147	)		(100.4	)		(8,461,493	)		(69.6	)		(3,544,653	)		41.9

	For the Nine Months Ended
	September 30,		September 30,
	2022		2021
Compensation for vesting of restricted stock awards issued to the Board of Directors	$	153,375	$	148,125
Compensation for vesting of restricted stock awards issued to management		628,985		206,858
Total Non-Cash Compensation	$	782,360	$	354,983

●	The assessment of revenue recognition, which impacts revenue and cost of sales;
●	the assessment of allowance for product warranties, which impacts gross profit;
●	the assessment of collectability of Accounts receivable, which impacts operating expenses when and if we record bad debt or adjust the allowance for doubtful accounts;
●	the assessment of recoverability of long-lived assets, which impacts gross profit or operating expenses when and if we record asset impairments or accelerate their depreciation;
●	the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions), which impact our provision for taxes;
●	the valuation of inventory, along with the reserve for excess and obsolescence, which impacts gross profit; and
●	the recognition and measurement of loss contingencies, which impact gross profit or operating expenses when we recognize a loss contingency, revise the estimate for a loss contingency, or record an asset impairment.

~~3.1~~ 10.1		~~Articles of Incorporation, as amended as of April 28,~~Executive Services Agreement, dated July 26, 2022, by and between LiqTech Holding A/S and Fei Chen	~~Filed herewith~~	Incorporated by reference to Exhibit 10.1 to the Company’s current report on Form 8-K, filed with the SEC on August 1, 2022.

~~10.1~~	~~Separation Agreement and Release between LiqTech International A/S and Sune Mathiesen dated May 11, 2022~~	~~Filed herewith~~

31.1		Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002		Filed herewith

31.2		Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002		Filed herewith

32.1		Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002		Furnished herewith

32.2		Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002		Furnished herewith

101. INS		Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)		Provided herewith

101. CAL		Inline XBRL Taxonomy Extension Calculation Link base Document		Provided herewith

101. DEF		Inline XBRL Taxonomy Extension Definition Link base Document		Provided herewith

101. LAB		Inline XBRL Taxonomy Label Link base Document		Provided herewith

101. PRE		Inline XBRL Extension Presentation Link base Document		Provided herewith

101. SCH		Inline XBRL Taxonomy Extension Scheme Document		Provided herewith

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).		Provided herewith

	LiqTech International, Inc.

Dated: ~~May 12,~~November 10, 2022	/s/ ~~Alexander J. Buehler~~Fei Chen
	~~Alexander J. Buehler, Interim~~Fei Chen, President and Chief Executive Officer
	(Principal Executive Officer)


Dated: ~~May 12,~~November 10, 2022	/s/ Simon S. Stadil
	Simon S. Stadil, Chief Financial Officer
	(Principal Financial and Accounting Officer)